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Abstract
Background: Work is a central resource for cancer survivors as it not only provides income but also impacts health
and quality of life. Additionally, work helps survivors to cope with the perceived critical life event. The German
Pension Insurance provides medical rehabilitation for working-age patients with chronic diseases to improve and
restore their work ability, and support returning to or staying at work, and thus tries to sustainably avoid health-
related early retirement. Past research showed that conventional medical rehabilitation programs do not support
returning to work sufficiently and that work-related medical rehabilitation programs report higher return-to-work
rates across several health conditions, when compared to medical rehabilitation. Therefore, the current study
protocol outlines an effectiveness study of such a program for cancer survivors.
Methods: To evaluate the effectiveness of work-related medical rehabilitation in cancer patients we conduct a
cluster-randomized multicenter trial. In total, 504 rehabilitation patients between 18 and 60 years with a Karnofsky
Performance Status of ≥70 %, a preliminary positive social-medical prognosis of employability for at least 3 h/day
within the next 6 months and an elevated risk of not returning to work will be recruited in four inpatient
rehabilitation centers. Patients are randomized to the work-related medical rehabilitation program or the
conventional medical rehabilitation program based on their week of arrival at each rehabilitation center. The
work-related medical rehabilitation program comprises additional work-related diagnostics, multi-professional team
meetings, an introductory session as well as work-related functional capacity training, work-related psychological
groups, and social counseling. All additional components are aimed at the adjustment of the patients’ capacity in
relation to their individual job demands. Role functioning defines the main study outcome and will be assessed
with the EORTC-QLQ30. Secondary outcome measures are the remaining scales of the EORTC-QLQ30, fatigue,
self-rated work ability, disease coping, participation in working life, realization of work-related goals and therapies
during rehabilitation, and treatment satisfaction.
Discussion: A positive evaluation of work-related medical rehabilitation in cancer patients is expected due to the
promising findings on the effectiveness of such programs for patients with other health conditions. Results may
support the dissemination of work-related medical rehabilitation programs in German cancer rehabilitation.
Trial registration: German Clinical Trials Register DRKS00007770. Registered 13 May 2015.
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Background
With approximately 14.1 million new cases in 2014, cancer
is one of the leading causes of morbidity worldwide [1].
Europe alone accounts for 24.4 % (approximately 3.44 mil-
lion cases) of the worldwide incidence. The prostate
(22.8 %), lung (15.9 %), and colorectum (13.2 %) are the
most prominent cancer sites among men in Europe. Among
women, the breast (28.8 %), colorectum (12.7 %), and lung
(7.4 %) are the most frequently affected sites [1]. These
numbers also mirror the current situation in Germany
where 477,300 incident cases were reported for 2010 [2].
Due to better screening and treatment of cancer, sur-
vival rates in cancer patients have improved steadily over
the last few years in most developed countries. Five-year
survival rates for cancer improved for patients diagnosed
between 2005 and 2009 in most developed countries
when compared to 5-year survival rates between 1995
and 1999 (e.g. Germany: 48.7 to 64.6 % for colon cancer,
51.9 to 62.1 % for rectal cancer, 81.2 to 85.3 % for breast
cancer) [3]. As a result, the life situation of cancer survi-
vors and their participation in different life domains re-
ceived increasing attention from patients, clinicians, and
researchers [4]. One of these important life domains is
work. Work not only provides income to afford living, it
also helps to structure time, enables social contacts, and
develops skills and personality [5, 6]. The presence or
absence of work has an impact on various facets of
health and quality of life [7, 8]. Work also has a positive
influence on coping with a disease (e.g. stroke [9, 10];
psychiatric disorders [11]; multiple sclerosis [12]). For
cancer survivors, returning to work after cancer diagno-
sis and subsequent treatment may support their ability
to cope with this critical life event and represents a
major step in restoring normality [13–16].
Although up to 75 % of cancer survivors previously
working in a job return to it after treatment [17], return-
ing to work is often easier said than done. Cancer survi-
vors are 1.4 times more likely to be unemployed
compared to healthy controls [18]. They also have an in-
creased risk of early retirement and are less likely to be
re-employed [18, 19]. Reviews showed that a multitude
of parameters influence the process of returning to work
in cancer survivors, including health, well-being and
symptoms, and different domains of functioning, as well
as self-rated work ability and work-related factors such
as job demands and the working environment [18–22].
In line with general return-to-work (RTW) research [23],
RTW in cancer survivors can therefore be described as a
multifaceted bio-psycho-socially moderated process. Con-
sequently, comprehensive multidisciplinary rehabilitation
strategies are favored for supporting RTW. A Cochrane
review by de Boer et al. [19] confirmed that only diverse,
multidisciplinary interventions show moderate evidence
of higher RTW rates for cancer survivors when compared
to usual care (for a comprehensive review across several
health conditions, please see Hoefsmit et al. [24]). Estab-
lished programs, however, are not necessarily multidiscip-
linary and often lack a specific focus on RTW [25]. In
Germany, the German Pension Insurance (GPI) provides
medical rehabilitation (MR) for working-age patients with
chronic diseases to improve and restore their work ability,
and support returning to or staying at work, and thus tries
to sustainably avoid health-related early retirement. In
Germany, about one fifth of all rehabilitation measures are
provided due to cancer [26]. However, though improve-
ment and restoration of work ability are the primary aims
of German MR programs, conventional MR does not
seem to address work-related issues sufficiently [27, 28].
The evidence considering the effects of these programs on
work-related outcome measures in cancer patients is
mixed at best. Most studies that are available did not use a
control group and focused only on generic health-related
outcome measures. These studies showed that MR can in-
crease health-related quality of life, physical functioning,
and general mental well-being [29–32], and decrease anx-
iety and depression [33]. Several studies, however, showed
that, in particular, persons with a poor self-rated RTW
prognosis did not benefit from conventional MR [34, 35].
Moreover, Weis and colleagues [32], who investigated the
work-related impact of inpatient rehabilitation in female
breast cancer patients in a controlled study, found no
sustainable effects on health- or work-related outcomes
[36]. Obviously, conventional MR as practiced in Germany
is not a sufficient treatment to address the multifaceted
factors of RTW in cancer survivors.
As a result, rehabilitation programs with a stronger
focus on work, work ability, and RTW have been devel-
oped in recent years. By addressing the individual job de-
mands and necessary skills to meet them, these programs
aim to increase the chances of a sustainable participation
in the labor market, especially for patients with more se-
vere restrictions of their work ability (e.g. long or repeated
periods of sick leave, unemployment, poor self-rated RTW
prognosis). To provide a framework for these diverse pro-
grams and activities, the GPI published guidelines for the
implementation of work-related medical rehabilitation
(WMR) [37]. These guidelines define the target group,
describe specific work-related diagnostic measures, and
explain the core therapeutic modules that complement
WMR programs as compared to conventional MR. The
definition of the target group, i.e. patients on long-
term sick leave and patients with a poor self-rated
RTW prognosis, also includes recommendations for
the identification of these patients by naming several
screening instruments that assess an elevated risk of
permanent work disability. The diagnostic process in
WMR is described as demand-oriented, meaning that
it should assess physical and psycho-social work
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ability against the background of the individual work-
related demands. This also includes the identification
of individual and environmental risk factors and re-
sources that might be related to coping with these de-
mands. Additionally, a functional capacity evaluation
should be part of the diagnostic procedure [38, 39].
Finally, the core therapeutic modules of WMR as de-
scribed by the guidelines are a) work-related functional
capacity training, b) work-related psychological groups,
and c) intensified social counseling [37].
Randomized controlled trials in patients with muscu-
loskeletal [40, 41], cardiac [42], neurological [43], and
psychosomatic disorders [44, 45] showed that patients
who received WMR reported significantly higher RTW
rates than patients who received a conventional MR pro-
gram. Though WMR is well established for several disor-
ders, there are currently only a few WMR programs for
cancer patients. One non-randomized clinical trial in
cancer patients showed no differences in RTW rates,
work-related stress, and job satisfaction between a WMR
group and a conventional MR group [46]. A major
methodological shortcoming of this study was the imbal-
ance of both groups regarding several baseline measures.
Moreover, the description of the program indicates that
it was not a comparably comprehensive strategy as de-
scribed in the current guidelines for WMR. Therefore,
we designed a study to determine the effects of well-
implemented WMR programs on work-related and
quality-of-life outcomes in cancer survivors.
Methods
Design
The study is designed as a cluster-randomized multicen-
ter trial which is realized in four German rehabilitation
centers: the Klinik Bavaria in Freyung, the Paracelsus-
Klinik am See in Bad Gandersheim, the MediClin Rose
Klinik Horn-Bad Meinberg, and the Röpersbergklinik in
Ratzeburg. The control group receives conventional MR
as prescribed by the German Pension Insurance, whereas
the intervention group receives a WMR program. Patients
are randomized in clusters. These clusters are defined by a
shared start of the rehabilitation program. Randomization
is stratified by centers.
Recruitment
Patients are informed about the study by a study nurse
or a physician in charge and have to provide written in-
formed consent prior to study participation. Participants
can withdraw their consent at any time without any con-
sequences. No modifications to the intervention are
planned. All rehabilitation centers were provided with a
process description for recruitment prior to the study
start and follow the same procedure.
When giving informed consent to participate in the
study, the name and address will be listed by the re-
habilitation center and a study number will be assigned.
This study number will be entered in a field on each
questionnaire. The study number will be also added to
the medical discharge letter while all information on
name and address will be removed to ensure that re-
search data and confidential data cannot be linked. The
study list with personal data and the study number will
be destructed at the end of the study (12/31/2017) by
each rehabilitation center to ensure that names and
addresses of study participants are no longer available.
The researchers receive a copy of this study list only
for mailing the questionnaires 3 and 12 months after
discharge. Use of these data is not allowed for any other
purpose but sending out the questionnaires. The study
list will be secured with a password, stored separately
from the collected research data, and erased after send-
ing out the last questionnaires. The time schedule of en-
rolment and interventions is displayed in Table 1.
Treatment
Control
Participants in the control group receive a conventional
MR as provided by rehabilitation centers in Germany.
Conventional MR is usually a 3-week program with an
overall amount of 60–75 h of therapy [26]. This includes
exercise therapy, physiotherapy, social counseling, occu-
pational therapy, psychological seminars and counseling,
and dieting. Participants in the control group do not re-
ceive intensified work-related therapies. However, social
counseling as an obligatory part of conventional MR in-
forms on social law and provides basic knowledge about
the rights of persons with disabilities. This also includes
work-related issues.
Intervention
Participants in the intervention group receive a WMR
program. In addition to the conventional MR, the WMR
includes additional work-related therapies as defined by
the WMR guideline (see above) [37]. This guideline pre-
scribes at least 11–25 h of additional work-related content
for WMR patients [37]. The complete treatment dose of a
WMR program contains up to 100 h of therapy.
The intervention content is guided by the WMR
guidelines [37]. Further specifications of the diagnostic
and therapeutic procedures are achieved in collaboration
with the rehabilitation centers, based on an implementa-
tion phase before the start of the initial trial. This imple-
mentation phase is aimed at increasing the feasibility and
fidelity of therapies across all participating rehabilitation
centers. This phase is also used to check whether centers
prescribe WMR therapies in addition to conventional
MR therapies for the intervention groups and that control
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groups only receive conventional MR. The additional
content of WMR and work-specific therapies as well as
their minimum amount of time are described below
(see Table 2 for a brief overview).
Additional work-related diagnostics Additional work-
related diagnostics are carried out by the physician in
charge, a psychologist and an occupational therapist or
physiotherapist directly after admission of the patients.
The diagnostic procedures are aimed at a comprehensive
assessment of work functioning. Work functioning is
understood as the result of the interaction between the
health problem on the one hand and work-related envir-
onmental and personal factors on the other. Restrictions
in work functioning can be related to body functions
and structures, activities, and participation [47, 48]. Each of
the three involved professions makes its own specific con-
tribution to the comprehensive assessment. The physician
primarily focuses on body functions and structures (e.g.
impairments). The psychological assessment, comprising
interview techniques as well as standardized instruments,
focuses on environmental (e.g. support of co-workers and
supervisor) and personal (e.g. coping styles) factors that
impact work functioning positively as resources and skills
or negatively as barriers. Finally, the occupational therapist
or physiotherapist assesses the ability to perform work ac-
tivities by using standardized tests of functional capacity
evaluation or structured observations of non-standardized
job tasks [38, 39]. The complete diagnostic process takes
at least 60 min. The medical and the psychological assess-
ment take at least 15 min each. The assessment of work-
related functional capacity takes at least 30 min. On the
basis of the diagnostic findings, the multi-professional
team jointly develops a comprehensive rehabilitation plan
with a tailored treatment strategy for each patient.
Multi-professional team meetings Multi-professional
team meetings are carried out once a week by the WMR
team, i.e. by the physician in charge, the psychologist, the
social worker, and at least one occupational therapist and
physiotherapist. The meetings provide a platform for mu-
tual exchange about the single patients assigned to the
WMR program (case conference). Besides facilitating and
bundling communication about the patients, the meetings
also aim to coordinate the single WMR elements provided
by the different team members to achieve concerted ac-
tion. The first meeting takes place directly after the afore-
mentioned diagnostic procedures to jointly develop a
rehabilitation plan and treatment strategy for each patient,
focusing on the enhancement of work functioning. In the
second meeting all team members report on the patients’
progress and current situation, assessed or observed dur-
ing or alongside the different therapeutic interventions. If
necessary, rehabilitation plans and treatment strategies are
adjusted. In the last meeting the individual rehabilitation
outcomes are evaluated. Based on this evaluation the final
decision on return to work or prolonged sick leave is dis-
cussed within the team. Moreover, additional measures
and benefits to support return to work are talked about; if
needed, recommendations are given to the GPI. Each
team meeting takes at least 30 min.
Introductory session The introductory session informs
all patients who participate in the WMR program about
the structure, content, and aims of the program. Each
therapist is introduced with their field of expertise so pa-
tients can identify the right person to address expertise-
related questions. The session is organized as a group
presentation, which is held by a physician at the beginning
of the WMR program and takes a minimum of 30 min.
The session is aimed at 1) getting patients familiar with
the program right from the beginning of their treatment,
2) initiating a treatment collaboration between patients
and therapists (i.e. a respectful and trustful relationship
between patient and therapist) by providing a transparent
structure, and 3) motivating patients to actively participate
Table 1 Time schedule of enrolment and interventions
Study period
Enrolment Allocation Post-allocation Close-out











Work-related medical rehabilitation X
Conventional medical rehabilitation X
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in their therapy by providing additional information about
the potential benefits of the program.
Work-related functional capacity training Work-re-
lated functional capacity training is carried out by an occu-
pational therapist or a physiotherapist in group or personal
sessions. Based on diagnostic results and following princi-
ples of graded activity (e.g. [49]), an individualized training
plan is developed for each WMR patient to purposively in-
crease work-related capacity and facilitate work-related
performance. Graded activity comprises regular training
with general exercises, strengthening exercises, and tailored
exercises that imitate individually relevant physical tasks by
making use of operant-conditioning behavioral principles
with the aim of restoring functioning. The primary aim is
not pain relief. However, participants learn that despite
pain symptoms, exercise and physical activity are safe and
recommended [49]. Following these principles, training
plans not only contain single or one-dimensional motion
tasks (e.g. latissimus pull-down exercise), but also complex
and multidimensional tasks (e.g. lifting and carrying bricks,
tightening bolts overhead, filling a goods shelf, patient
transfer) to simulate realistic work-related demands
and situations. Simultaneously, therapists train patients in
ergonomic working by implementing ergonomics in the
regular training (e.g. ergonomic corrections when lifting
goods onto a shelf).
Since cognitive impairments (as a symptom, result, or
side effect of the disease or its treatment) are often reported
by cancer survivors, this module also comprises cognitive
training sessions. Amongst others, computer-assisted train-
ing or group sessions under the guidance of a therapist are
used to improve attention, concentration, memory, and
logical thinking. Work-related functional capacity training
requires a minimum of 360 min of therapy.
Work-related psychological groups Work-related psy-
chological groups are provided by a psychologist and
have the purpose of supporting the concrete RTW
process of each patient by focusing on personal and
Table 2 Brief overview of the WMR program











Test of functional capacity










Assessment of work functioning and its restrictions
related to body functions and structures as well as
activities and participation
Assessment of environmental and personal factors
that impact work functioning positively as resources
and skills or negatively as barriers
Use of structured patient interviews and/or standardized
assessment instruments as well as standardized tests of
functional capacity evaluation, structured observations










Individual case conference for each patient
After admission: results of the work-related diagnostics,
joint development of a treatment plan
During the course of rehabilitation: development of the
patient, adjustment of the treatment plan if needed
Before discharge: evaluation of rehabilitation outcomes,
return-to-work prognosis, additional measures to
support return to work if needed
Introductory session After admission Presentation in
front of all WMR
patients
Physician Description of the aims of WMR, explanation of the
program structure and each module, introduction of
the rehabilitation team












Complex and multidimensional tasks to simulate
realistic work-related demands and situations
Integrated ergonomic and cognitive training
Work-related
psychological groups




Seminars focusing on work-related stress and coping,
work-related social competencies in communication,
and planning the concrete return to work
Intensified social
counseling








Social worker Clarification of the problematic work-related situations
and perspectives, information and consultation on
social law-related topics as well as measures and
benefits to support return to work, establish contact
with employer and request further measures and
benefits from the social or health services agencies
if needed
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environmental factors. In the group sessions the patients
are encouraged to reflect critically on their current job
situations and past work-related behaviors and on how
they might be able to adjust themselves or the situations
accordingly. Therefore, the patients learn about stress
and its influence on health and work ability and are
taught about diverse coping strategies (e.g. active coping,
seeking instrumental or emotional support, positive re-
evaluation). Group work is used to deepen the newly ac-
quired knowledge and to transfer it to individual condi-
tions. Techniques for immediate stress reduction such
as progressive muscle relaxation, autogenic training, and
meditation are shown and practiced to support coping.
Additionally, communication theories and techniques
are presented to the patients focusing on interpersonal
relationships and communication with colleagues and
supervisors. Role plays that take up realistic or even per-
sonally experienced situations at the workplace can be used
to put the theory into practice. As part of work-related
psychological groups, the patients learn how to apply
meta-cognitions on how to achieve their RTW aims in
the best possible way. To do so, they have to develop
and schedule concrete RTW plans for the time after
discharge from rehabilitation, taking into consideration
also potential problems and barriers, as well as strategies to
tackle them. Questions to clarify are: “What?”, “When?”,
“With whom?”, “How?”, and “What if?”. Plans are created
by considering the RTW framework that is provided as the
final result of social counseling. Work-related psychological
groups cover at least 240 min of group therapy. Additional
personal counseling can be provided at the request of
the patient.
Intensified social counseling Additional social counsel-
ing is carried out by a social worker in group and in in-
dividual sessions. It is aimed at the clarification of the
problematic work-related situations and perspectives of
WMR patients by providing them with extra information
and advice on social law and services. The social worker
develops the RTW framework jointly with the patient and
identifies which additional measures and benefits are
needed and available to achieve RTW in each specific
case. Such measures and benefits cover a broad scale of
possible instruments and range from modifications of the
work environment (e.g. height-adjustable desks) through
vocational retraining (e.g. achieving a new professional
title), to wage substitutes. The social worker requests
the individually indicated measures and benefits from
the social or health services agencies (e.g. GPI, health
insurance, integration office). If needed and wanted
by the patients, the social worker also establishes contact
with the employer to facilitate the transition from the re-
habilitation center back to the workplace (e.g. by initiating
graded RTW or modifications of the work environment).
The group sessions take at least 60 min. The personal
counseling takes at least 30 min.
Participants
Cancer patients (ICD-10: C00-D48) aged 18 to 60 years
are included in the study if they have a score of ≥70 %
on the Karnofsky Performance Status Scale [50, 51]
and a preliminary positive social-medical prognosis of
employability for at least 3 h/day within the next
6 months as assessed by the rehabilitation physician in
the initial examination after starting the rehabilitation
program. Moreover, patients are only eligible to par-
ticipate if they have an elevated risk of not returning to
work. This risk is assessed by the Screening Instrument
Work and Occupation (German: Screening-Instrument
Beruf und Arbeit in der Rehabilitation, SIBAR) [52–
54]. This screening consists of three subscales. The
first subscale is a 9-item scale and assesses the risk of
health-related early retirement on the basis of a
weighted sum score of several risk indicators (e.g. sick
leave duration and the patients’ belief of time to return
to work). A score of more than 7 out of 19 possible
points indicates an elevated risk of early retirement
and thus a need for a WMR program. The second sub-
scale is a 1-item score and assesses the amount of per-
ceived job strain. The third scale is also a 1-item score
and assesses the subjective need for work-related ther-
apies during the rehabilitation program. If patients in-
dicate a very stressful job situation or assume that
work-related therapies will be very helpful, this is also
taken as a marker of the need for a WMR program. In
brief, patients are included if one of the three scales in-
dicates a need for a WMR program. Previous studies
estimated that this is the case for about half of the pa-
tients. Moreover, about a quarter of the patients has an
elevated risk of early retirement based on the first scale
of the SIBAR [52–54]. No exclusion criteria were
defined.
Randomization
The study is designed as a cluster-randomized multicen-
ter trial. Patients are recruited from four inpatient re-
habilitation centers. Patients of a rehabilitation center
who start their rehabilitation in the same week represent
a cluster. These patients jointly receive either the inter-
vention or the control treatment. Cluster-randomization
was chosen to avoid spillover effects between therapy
groups. Each of the four rehabilitation centers receives
its own randomization schedule. The randomization
lists are created by the last author using computer-
generated random numbers and blocks of 4. The
administrative employees who assign the patients to
their date of rehabilitation are blinded to the random-
ization schedule.
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Sample size calculation
Sample size calculation was done to detect a standardized
mean difference (SMD) of SMD= 0.3 in the primary out-
come with 80 % power and a two-sided alpha error of 5 %.
Using a t-test, a sample size of 352 participants would be
needed. The planned regression modeling of treatment
effects, which includes the baseline measurement of the
primary outcome as a covariate, needs a sample size that
is reduced by the factor 1 - r2 [55]. The correlation r rep-
resents the correlation between baseline and follow-up
measurement. The approximation of the sample size
based on a t-test represents a conservative proxy, even
when considering the design effects induced by the
cluster-randomization or missing values. Based on ex-
pected sample attrition due to nonresponse to the 1-year
follow-up questionnaire of 30 %, we aim to recruit at least
504 patients.
Outcome measures
Primary and secondary outcomes are assessed by ques-
tionnaires at the beginning of the inpatient rehabilitation
program, at discharge from the rehabilitation program,
and 3 and 12 months after discharge. Questionnaires at
the beginning and discharge of the program are delivered
and collected by study nurses in the rehabilitation centers.
These nurses are not blinded to the treatment allocation.
Questionnaires at 3- and 12-month follow-up are sent by
mail to the first author who is also not blinded to the treat-
ment allocation. Table 3 shows all variables and their cor-
responding measurement point.
In the case of nonresponse to the follow-up question-
naires at 3 and 12 months after discharge, participants re-
ceive three additional reminders. The first reminder
consists of a letter and is sent one week after the initial
follow-up questionnaire; the second reminder includes the
questionnaire again and is sent three weeks after the initial
follow-up questionnaire; the third reminder also includes
the questionnaire again and is sent six weeks after the
initial follow-up questionnaire.
Main study outcome
The primary outcome of the study is the role function-
ing scale of the 30-item quality-of-life questionnaire of
the European Organization for Research and Treatment
of Cancer (EORTC QLQ-30). The role functioning scale
comprises two items that relate to a) work and other
daily activities and b) hobbies and leisure time activities.
Response categories are “not at all,” “a little,” “quite a bit,”
and “very much.” Single-item scores will be averaged and
transformed to a score from 0 to 100 points. Higher scores
represent better functioning [56].
Table 3 Time schedule of assessments and instruments
Admission Discharge 3-month follow-up 12-month follow-up
Role functioning (EORTC QLQ-C30) [56] X X X
Physical functioning (EORTC QLQ-C30) [56] X X X X
Emotional functioning (EORTC QLQ-C30) [56] X X X X
Social functioning (EORTC QLQ-C30) [56] X X X
Pain (EORTC QLQ-C30) [56] X X X X
Global health (EORTC QLQ-C30) [56] X X X X
Fatigue (EORTC QLQ-FA13) X X X X
Coping with illness (FCQI) [60] X X X X
Implementation of work-related therapies [63] X
Consistency of work-related rehabilitation strategy [63] X
Benefit from work-related therapies [63] X
Work Ability Score [59] X X X X
Employment status X X X
Time of return to work X X
Sick leave duration X X X
Disability days during the last 3 months [61] X X X
Patient satisfaction [64] X
Sociodemographic data X
Discrete choice experiment X
Screening Instrument Work and Occupation [67] X
EORTC QLQ-30 30-item quality-of-life questionnaire of the European Organization for Research and Treatment of Cancer; EORTC QLQ-FA13 13-item fatigue
questionnaire of the European Organization for Research and Treatment of Cancer; FCQI Freiburg Questionnaire of Coping with Illness
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Secondary study outcome
Secondary outcome measures are additional scales of the
EORTC QLQ-30. These scales measure physical functioning,
emotional functioning, social functioning, pain, and global
health [56, 57]. Additionally, we use the 13-item fatigue
module (EORTC QLQ-FA13) [58]. All scales range from 0
to 100 points. Higher scores indicate a better health-
related quality of life.
Self-rated work ability is measured with the Work Ability
Score. Ten points represent the best work ability ever
achieved; 0 points indicate total work disability [59].
Disease coping is measured with three scales of the
Freiburg Questionnaire of Coping with Illness (FCQI;
depressive coping, active coping, distraction, and self-en-
couragement) with 5-point scaled items [60]. Raw item
scores will be added up to a sum score for each scale.
These will be used to calculate a mean scale score, result-
ing in values ranging from 1 to 5 points [60].
Participation in working life is measured with an as-
sessment of the current employment status, current sick
leave status, and disability days during the last 3 months
[61, 62]. The assessment after 12 months also includes a
question regarding the date of initial return to work.
The realization of work-related goals and therapies
during rehabilitation is assessed with a slightly modified
version of a previously used set of items from a study
that investigated the implementation of the WMR guide-
lines [63]. Participants report on 12 dichotomized items
whether they received WMR contents throughout their
rehabilitation program. Scores are aggregated to a total
score ranging from 0 to 12 points. This score reflects
the implementation of the work-related therapies.
Additionally, 6 items assess the perceived diagnostic
and therapeutic focus on issues of return to work and
work ability, e.g. the experience of a consistent RTW
strategy. These items are 5-point scaled. Scores will be
summed to a total score ranging from 0 to 24 points.
Finally, the subjective work-related benefit from par-
ticipating in the rehabilitation program is assessed with
8 items using 5-point scales. Scores are aggregated to a
total score ranging from 0 to 32 points.
Treatment satisfaction is assessed using the German ver-
sion of the Client Satisfaction Questionnaire (CSQ-8) [64].
This questionnaire uses 8 items to assess various aspects of
the patient’s satisfaction with the treatment. Items are 4-
point scaled. The sum score ranges from 8 to 32 points.
Supplemental data
The sociodemographic data that are assessed include age,
sex, employment status, native language, partnership,
number of children, educational level, and job qualifica-
tion. Additionally, a discrete choice experiment is attached
to the baseline questionnaire to assess patients’ treatment
preferences [65].
Data management
Questionnaires will be scanned and verified by an elec-
tronic data capture system and exported to statistical soft-
ware packages for further analysis. Scanning and verifying
is done by trained research assistants. Research assistants
check electronically processed data item by item and com-
pare imported data with the original questionnaire data.
If available, standard syntaxes are used to calculate
scales (e.g. symptom scales of the EORTC QLQ-30) for
further analyses. Each data set is checked for errors or
inconsistencies before merging them with data from the
other data sources or time points via the assigned study
number to create a comprehensive data set. Data access
is limited to the authors and the research assistants of
the research team at the University of Lübeck.
Statistical analysis
Treatment effects are tested using regression analyses.
In the case of binary study outcomes, logistic regression
will be used (e.g. effects on employment status or sick
leave at follow-up). For analysis of time to return to
work, we will use proportional hazard models. Baseline
parameters will be considered as covariates [66]. Due to
the cluster-randomization, the induced correlation of
error terms for patients with the same arrival week will be
taken into account by a random effect [67–69]. Rehabilita-
tion centers will be considered using a fixed effect.
To calculate a SMD of the between-group difference,
the unstandardized regression coefficient estimate of the
treatment effect will be used [70]. This estimate will be
standardized using the pooled standard deviation of the
observed follow-up scores [71]. In the case of binary
study outcomes, estimated odds ratios will be trans-
formed into SMDs using a logit-transformation [71, 72].
SMDs will be interpreted as suggested by Cohen [73]:
small effect: SMD ≥0.2, medium effect: SMD ≥0.5, large
effect: SMD ≥0.8.
Furthermore, to test whether the treatment effect on
the primary outcome is moderated by other variables we
will include two-way interaction terms in the regression
model. Potential moderators that will be tested are the
remaining EORTC QLQ-30 scales, fatigue, the Work
Ability Score, disease coping, and the type of rehabilita-
tion (rehabilitation following primary cancer treatment
vs. follow-up rehabilitation) as well as sociodemographic
variables. Continuous moderators will be standardized
using a z-transformation. The parameter estimate of the
interaction between the z-standardized continuous score
and the treatment indicator then represents the additional
treatment effects when increasing the potential moderator
by about one standard deviation [74–76]. Patients will be
included in our analyses if they have completed the corre-
sponding follow-up questionnaire and will be analyzed as
randomized, i.e. as intended to treat [77]. Differences will
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be regarded as significant if the two-sided p-value of a test
is less than 0.05.
Missing observations are excluded from the primary
analysis. Supplementary analyses will impute missing ob-
servation by using the last observation carried forward
method, in which the last observed value is used in place
of the missing endpoint. No stopping guidelines are ap-
plied and no adverse health events are expected.
Discussion
Due to the increasing survival rates of cancer patients, the
specific role of RTW in coping with the disease, and the
higher risk of being excluded from the labor market, a
clear need for interventions that support work-related
outcomes can be identified. The study will provide highly
ranked evidence for or against the effectiveness of WMR
in cancer patients when compared to conventional MR.
Positive results in favor of WMR might be expected con-
sidering the already existing body of evidence regarding
WMR for other health conditions [40–45]. The current
study addresses the shortcomings of previous studies by
applying a randomized controlled study design and
ensuring implementation of the WMR programs ac-
cording to current guidelines in all participating cen-
ters. A positive evaluation of WMR in cancer patients
might support the dissemination of WMR programs in
German cancer rehabilitation.
Trial status
The implementation of the work-related medical rehabili-
tation program in all participating rehabilitation centers is
finished. Patient recruitment started in June 2015 and is
ongoing. For regular updates, please check the trial register
entry. Items from the World Health Organization trial
registration data set are presented in Additional file 1.
Additional files
Additional file 1: Table S1. World Health Organization trial registration
data. (DOCX 19 kb)
Additional file 2: SPIRIT 2013 Checklist. (DOC 123 kb)
Additional file 3: Translated study information for rehabilitation
patients. (DOCX 53 kb)
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